Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety study of MMR vaccine in infants 8–9 months
CTR20211045Phase 4Completed
- Sponsor
- Sinopharm
- Start
- May 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Measles, Mumps, and Rubella Vaccine Live in measles, mumps, rubella, sponsored by Sinopharm. Started May 2021; status: completed.
02
Drugs
Measles, Mumps, and Rubella Vaccine Live
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on CTR20211045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211045.